125 related articles for article (PubMed ID: 1474715)
1. [Urinary disturbance due to HTLV-1 associated myelopathy].
Sakiyama H; Nishi K; Kikukawa H; Ueda S
Nihon Hinyokika Gakkai Zasshi; 1992 Dec; 83(12):2058-61. PubMed ID: 1474715
[TBL] [Abstract][Full Text] [Related]
2. Voiding dysfunction in patients with human T-lymphotropic-virus-type-1-associated myelopathy.
Komine S; Yoshida H; Fujiyama C; Masaki Z
Urol Int; 1991; 47 Suppl 1():67-8. PubMed ID: 1949381
[TBL] [Abstract][Full Text] [Related]
3. [Studies on neurogenic bladder due to human T-lymphotropic virus type-I associated myelopathy (HAM)].
Imamura A
Nihon Hinyokika Gakkai Zasshi; 1994 Jul; 85(7):1106-15. PubMed ID: 8078228
[TBL] [Abstract][Full Text] [Related]
4. Retrospective clinic and urodynamic study in the neurogenic bladder dysfunction caused by human T cell lymphotrophic virus type 1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Troisgros O; Barnay JL; Darbon-Naghibzadeh F; Olive P; René-Corail P
Neurourol Urodyn; 2017 Feb; 36(2):449-452. PubMed ID: 26756420
[TBL] [Abstract][Full Text] [Related]
5. Voiding dysfunction: patients with human T-lymphotropic-virus-type-1-associated myelopathy.
Yamashita H; Kumazawa J
Urol Int; 1991; 47 Suppl 1():69-71. PubMed ID: 1949382
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestation of human T-cell lymphotropic virus type-I-associated myelopathy and vesicopathy.
Imamura A; Kitagawa T; Ohi Y; Osame M
Urol Int; 1991; 46(2):149-53. PubMed ID: 2053222
[TBL] [Abstract][Full Text] [Related]
7. Prosultiamine for treatment of lower urinary tract dysfunction accompanied by human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis.
Matsuo T; Miyata Y; Nakamura T; Satoh K; Sakai H
Int J Urol; 2018 Jan; 25(1):54-60. PubMed ID: 28965354
[TBL] [Abstract][Full Text] [Related]
8. Urodynamic features of the voiding dysfunction in HTLV-1 infected individuals.
Castro NM; Freitas DM; Rodrigues W; Muniz A; Oliveira P; Carvalho EM
Int Braz J Urol; 2007; 33(2):238-44; discussion 244-5. PubMed ID: 17488545
[TBL] [Abstract][Full Text] [Related]
9. Urinary dysfunction in tropical spastic paraparesis: preliminary urodynamic survey.
Walton GW; Kaplan SA
J Urol; 1993 Sep; 150(3):930-2. PubMed ID: 8345613
[TBL] [Abstract][Full Text] [Related]
10. Micturitional disturbance in human T-lymphotropic virus type-1-associated myelopathy.
Hattori T; Sakakibara R; Yamanishi T; Yasuda K; Hirayama K
J Spinal Disord; 1994 Jun; 7(3):255-8. PubMed ID: 7919650
[TBL] [Abstract][Full Text] [Related]
11. Bladder dysfunction due to human T-lymphotrophic virus type I associated myelopathy.
Saito M; Kondo A; Kato K; Gotoh M
Br J Urol; 1991 Oct; 68(4):365-8. PubMed ID: 1933155
[TBL] [Abstract][Full Text] [Related]
12. Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM).
Komine S; Yoshida K; Yamashita H; Masaki Z
Paraplegia; 1989 Jun; 27(3):217-21. PubMed ID: 2762009
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of neurogenic bladder due to HTLV-1 associated myelopathy (HAM)].
Namima T; Sohma F; Imabayashi K; Nishimura Y; Orikasa S
Nihon Hinyokika Gakkai Zasshi; 1990 Mar; 81(3):475-8. PubMed ID: 2359227
[TBL] [Abstract][Full Text] [Related]
14. [Neurogenic bladder in HAM (HTLV-I associated myelopathy)].
Saito M; Kato K; Kondo A; Miyake K
Hinyokika Kiyo; 1991 Sep; 37(9):1005-8. PubMed ID: 1785406
[TBL] [Abstract][Full Text] [Related]
15. Urinary and sexual manifestations of patients infected by HTLV-I.
Oliveira P; Castro NM; Carvalho EM
Clinics (Sao Paulo); 2007 Apr; 62(2):191-6. PubMed ID: 17505705
[TBL] [Abstract][Full Text] [Related]
16. Natural course of voiding function in patients with human T-cell lymphotrophic virus type 1-associated myelopathy.
Mori K; Noguchi M; Matsuo M; Nomata K; Nakamura T; Kanetake H
J Neurol Sci; 2004 Jan; 217(1):3-6. PubMed ID: 14675601
[TBL] [Abstract][Full Text] [Related]
17. [Bladder involvement in HTLV-I associated myelopathy].
Nomata K; Suzu H; Yushita Y; Kanetake H; Saito Y
Nihon Hinyokika Gakkai Zasshi; 1991 Jul; 82(7):1161-4. PubMed ID: 1895630
[TBL] [Abstract][Full Text] [Related]
18. Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis.
Yamakawa N; Yagishita N; Matsuo T; Yamauchi J; Ueno T; Inoue E; Takata A; Nagasaka M; Araya N; Hasegawa D; Coler-Reilly A; Tsutsumi S; Sato T; Araujo A; Casseb J; Gotuzzo E; Jacobson S; Martin F; Puccioni-Sohler M; Taylor GP; Yamano Y;
Orphanet J Rare Dis; 2020 Jul; 15(1):175. PubMed ID: 32620176
[TBL] [Abstract][Full Text] [Related]
19. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
Yamano Y; Sato T
Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
